The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
CRAB Alert: The EVS Role in Preventing Infection
Why Hospital Waiting Rooms Aren't Going Away
Ground Broken on Mount Sinai Tisch Cancer Hospital
Design, Compartmentation, Training: How Defend-in-Place Strategies Can Protect Patients
Milestone Marked with Topping Out Ceremony for BayCare Hospital Manatee